ExactAntigen

POLR2A antibody - ChIP assay | antibody review based on formal publications
POLR2A antibodies
This is a review about POLR2A antibodies, based on 22 published articles using POLR2A antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited POLR2A antibody.
Santa Cruz Biotechnology    search Santa Cruz Biotechnology POLR2A products
chipSanta-Cruz anti-RNA PolII antibody(H-224) was used in ChIP assay to study FoxA1 differential transcriptional activities in breast and prostate cancer cells and their functional relation with the epigenome of these cells. to the paper
chipSanta Cruz anti-RNA polymerase II(pol II) antibody(sc-899) was used in ChIP assay to study the recruitment of DOT1L and the patterning of mono-, di-, and trimethylation of H3K79 under dynamic conditions in mouse MEFs. to the paper
chipSanta Cruz Biotechnology anti-POLR2A antibody (cat. no. sc-899) was used in ChIP assay to study the binding patterns of three members of the E2F family in five human cell types. to the paper
chipSanta Cruz RNA pol II antibody was used in ChIP assay to study the roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. to the paper
chipSanta Cruz RPB1 antibody was used in ChIP assay to identify novel functional TBP-binding sites and general factor repertoires. to the paper
chipSanta Cruz Biotechnology anti-RNA polymerase II antibody was used in ChIP assay to study the role of IPS-1, IRF3, and IFN in Legionella infection of lung epithelium in human A549 cells. to the paper
chipSanta Cruz Biotechnology Pol II antibody (H-224) was used in ChIP assay to determine whether the G-rich sequence promotes transcriptional pausing and consequent termination activity in HeLa cells. to the paper
chipSanta Cruz Biotechnology POLR2A antibody was used in ChIP assay to demonstrate a widespread role for E2F1 in the human genome. to the paper
chipSanta Cruz Biotechnologies anti-phosphorylated RNA polymerase II (Pol II) was used in ChIP assays to check the transcriptional activity of the p21(waf1/cip1) promoter in MCF-7 human breast cancer cells. to the paper
chipSanta Cruz Biotechnology RNA polymerase II antibody [N-20] was used in ChIP assay to study the function of forkhead box M1 to regulate the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. to the paper
chipSanta Cruz Biotechnology RNA polymerase II antibody was used in ChIP assay to study the role of DNA replication factor MCM5 in Stat1-mediated transcriptional activation. to the paper
chipSanta Cruz Biotechnology polyclonal antibody against RNA polymerase II was used in CHIP assay to investigate the IL-8 and IkappaBalpha gene regulatory regions in A549 human lung carcinoma cells. to the paper
chipSanta Cruz Biotechnology anti-Pol II (N-20; sc-899) antibody was used in ChIP assays to study the control of endothelial nitric-oxide synthase expression. to the paper
chipSanta Cruz Biotechnology antibody to pol II was used in chromatin immunoprecipitation to study the coactivators and corepressors of NF-kappa B in I kappa B alpha gene promoter. to the paper
chipSanta Cruz Biotechnologies antibodies against Pol II (sc-899) and phosphorylated Pol II (sc-13583) was used in ChIP assays to indentify the human hyaluronan synthase 2 gene as a primary retinoic acid and epidermal growth factor responding gene. to the paper
chipSanta Cruz Biotechnology antibody against RNA Pol II (H-244) was used in chip assay to examine the dynamic association of RNAPII with the ERalpha-responsive promoters in human T47D cells. to the paper
chipSanta Cruz Biotechnology anti-RNA polymerase II NH2-terminal antibody(N20) was used in ChIP assay to study the role for antisense mRNA (sONE) in the post-transcriptional regulation of eNOS in human cell lines. to the paper
chipSanta Cruz Biotechnology RNA polymerase II antibody was used in ChIP assay to study transcriptional regulation of human luteinizing hormone receptor gene. to the paper
Millipore    search Millipore POLR2A products
chipUpstate anti-RNA polymerase II (anti-Pol II) antibody (clone CTD4H8) was used in ChIP assay to study the contribution of CSN5/Jab1 to ERα ligand-dependent degradation and the mechanism of transcription activation in response to estradiol. to the paper
Abcam    search Abcam POLR2A products
chipAbcam anti-RNA PolII antibody(Ab5408) was used in ChIP assay to study FoxA1 differential transcriptional activities in breast and prostate cancer cells and their functional relation with the epigenome of these cells. to the paper
BERKELEY ANTIBODY COMPANY
chipBerkeley Antibody Company monoclonal anti-Rpb1-CTD antibody 8WG16 was used in yeast and in ChIP assay to study the effect of an hpr1 point mutation on transcription and mRNP biogenesis. to the paper
COVANCE
chipCovance anti-the large subunit of RNA polymerease II antibody(8WG16) was used in ChIP assay to study the role for NF90 in regulating inducible IL-2 gene expression in mouse spleen cells. to the paper
chipCovance Research Products anti-RNA polymerase II (anti-Pol II) antibody (8WG16) was used in mouse cells and in ChIP assay to study the rapid establishment of an active transcriptional complex on PPAR target genes immediately following the ectopic expression of PPARs. to the paper
chipCovance anti-phosphorylated RNA polymerase II (Ser5) (H14) and anti-phosphorylated RNA polymerase II (Ser2) (H5) antibodies were used in ChIP assays to study the control of endothelial nitric-oxide synthase expression. to the paper
Articles Reviewed
1:David J Steger et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. 2008
2:Mathieu Lupien et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. 2008
3:Antonella De Luca et al. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. 2007
4:Sergey Denissov et al. Identification of novel functional TBP-binding sites and general factor repertoires. 2007
5:Xiaoqin Xu et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. 2007
6:Lingfang Shi et al. NF90 regulates inducible IL-2 gene expression in T cells. 2007
7:Pablo Huertas et al. An hpr1 point mutation that impairs transcription and mRNP biogenesis without increasing recombination. 2006
8:Mark Bieda et al. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. 2006
9:Natalia Gromak et al. Pause sites promote transcriptional termination of mammalian RNA polymerase II. 2006
10:Anna Saramäki et al. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. 2006
11:Ronni Nielsen et al. Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery. 2006
12:Bastian Opitz et al. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. 2006
13:Zhanguo Gao et al. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. 2005
14:Jason E Fish et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. 2005
15:Katri Saavalainen et al. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. 2005
16:Hans F Luecke et al. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. 2005
17:Marylynn Snyder et al. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. 2005
18:I-Ching Wang et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. 2005
19:Mathilde Calligé et al. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. 2005
20:G Brett Robb et al. Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. 2004
21:Sarah E Aiyar et al. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. 2004
22:Ying Zhang et al. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002


2008©ExactAntigen home | browse | about